ON

OneMedNet Corporation

ONMDHealthcareNASDAQ

Health Information Services · Last scanned Sep 8, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.4M
+111.4% YoY
Net Income
-$2.8M
+72.3% YoY
EBITDA
-$2.7M
+73.1% YoY
Free Cash Flow
-$4.2M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 RSI OversoldRSI 15.3, below 30, stock may be oversold
Sep 2 RSI OversoldRSI 25.1, below 30, stock may be oversold
About OneMedNet Corporation

Part of the healthcare sector, OneMedNet Corporation (ONMD) is listed under Health Information Services. The $40.7M market capitalization puts ONMD squarely in micro-cap range for its industry. It offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets.

Where ONMD stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, ONMD finished 25.00% below its 150-day moving average ($0.76) and 35.96% below its 200-day moving average ($0.89). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ONMD overbought or oversold?

At the September 3, 2026 close, ONMD's RSI(14) was 15.3, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$40.7M
EPS$-0.17
Beta1.12
52W Change-18.0%
Analysis

On the balance sheet, ONMD has $358K in cash with $701K in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow is running at -$4.2M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Revenue has been uneven over recent years, ranging from $1.2M to $1.4M.

The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing ONMD's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms